FDA Gives Approval To Blood Cancer Drug Empliciti The FDA has granted approval to the use of the drug Empliciti in combination with two other drugs for treating patients with multiple myeloma. The drug Empliciti is the second FDA-approved monoclonal antibody used for multiple myeloma treatments. by Alyssa Navarro
Xi Jinping Warns Against Chip Restrictions During Talks with Dutch PM Rutte: 'No Force Can Stop China's Progress'
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband